New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
07:40 EDTINSY, ESRXInsys valuation could be $4 lower on Subsys exclusion, says Wells Fargo
After another research firm stated that Insys' (INSY) Subsys would be placed on Express Scripts' (ESRX) list of excluded drugs, Wells Fargo estimates that such a development could reduce Insys' valuation by about $4. The firm notes that the stock fell $4.16 on July 31 and August 1. It keeps an Outperform rating on the shares.
News For INSY;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 29, 2014
10:00 EDTINSYOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:59 EDTINSYInsys Therapeutics initiated with an Overweight at Piper Jaffray
Subscribe for More Information
October 28, 2014
16:07 EDTESRXExpress Scripts sees Q4 adjusted EPS $1.36-$1.40, consensus $1.38
Sees Q4 adjusted claims 317M-337M.
16:06 EDTESRXExpress Scripts narrows FY14 EPS view to $4.86-$4.90, consensus $4.88
Subscribe for More Information
16:05 EDTESRXExpress Scripts reports Q3 adjusted EPS $1.29, consensus $1.29
Reports Q3 revenue $25.78B, consensus $24.93B. Reports Q3 adjusted claims 328.3M.
07:21 EDTINSYCBI to hold a conference
Subscribe for More Information
October 22, 2014
09:23 EDTESRXExpress Scripts getting more aggressive on pricing, says Cleveland Research
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use